- ►sld.cu [PDF] DB Matchar, DC McCrory, LA Orlando, MR … - Annals of Internal Medicine, 2008 - Am Coll Physicians Data Sources: MEDLINE (1966 to May 2006), the Cochrane Central Register of
Controlled Trials (Issue 2, 2006), and selected reference lists were searched
for relevant English-language trials. The MEDLINE search was updated to ... Cited by 71 - Related articles - BL Direct - All 11 versions
- ►annals.org R Kunz, C Friedrich, M Wolbers, JFE Mann - Annals of Internal Medicine, 2007 - Am Coll Physicians This position paper concerns improving health care in the United States. Unlike
previous highly focused policy papers by the American College of Physicians,
this article takes a comprehensive approach to improving access, quality, ... Cited by 118 - Related articles - BL Direct - All 6 versions
- ►sld.cu [PDF] CO Phillips, A Kashani, DK Ko, G Francis, … - Archives of internal medicine, 2007 - archinte.highwire.org Methods MEDLINE (January 1966–December 2006) and Web sites for the National
Institute of Health Clinical Trials and the Food and Drug Administration were
searched for eligible RCTs that included 500 or more subjects, had a ... Cited by 73 - Related articles - BL Direct - All 7 versions
R Lakhdar, MH Al-Mallah, DE Lanfear - Journal of Cardiac Failure, 2008 - Elsevier Nine trials that enrolled 18,160 patients met the inclusion criteria. A total of
9199 patients received combination therapy, and 8961 patients received an ACEI
only. Patients receiving combination therapy had an increased risk of ... Cited by 19 - Related articles - All 17 versions
GL Bakris, L Ruilope, F Locatelli, A … - Kidney international, 2007 - nature.com Microalbuminuria independently predicts increased cardiovascular risk in
hypertensive patients, especially in those with concomitant diabetes or
established cardiovascular disease. Drugs that target the ... Cited by 38 - Related articles - BL Direct - All 4 versions
- ►hypertension.org.za [PDF] JFE Mann, RE Schmieder, M McQueen, L Dyal, … - The Lancet, 2008 - Elsevier 784 patients permanently discontinued randomised therapy during the trial
because of hypotensive symptoms (406 on combination therapy, 149 on ramipril,
and 229 on telmisartan). The number of events for the composite primary ... Cited by 141 - Related articles - All 62 versions
[CITATION] for the Scandinavian Study Group. Comparison of the angiotensin II antagonist losartan with …
JJV McMurray, JB Young, ME Dunlap, CB … - American Heart Journal, 2006 - Elsevier The benefit of candesartan was not modified by the dose of ACE inhibitor. In all
patients (n = 2548), the candesartan/placebo hazard ratio (HR) for the primary
outcome was 0.85 (95% CI 0.75-0.96). In patients taking a guideline ... Cited by 16 - Related articles - All 15 versions
[CITATION] Blood pressure-dependent and independent effects of agents that inhibit the renin- …
F Turnbull, B Neal, M Pfeffer, J Kostis, C … - J Hypertens, 2007 - Blood Pressure Lowering Treatment Trialists' Collaboration Cited by 47 - Related articles
T Hannedouche, M Godin, D Fries, JP … - Nephron, 1991 - content.karger.com Acute reversible renal failure is a widely recognized potential complication of
angiotensin-converting enzyme inhibitor (ACEI) administration in renovascular
hypertension, particularly in bilateral artery stenosis or stenosis ... Cited by 21 - Related articles - All 5 versions
